Pharmaceutical companies, scientists, and tech companies can no longer work in isolation if we are to see the biggest challenges in our health addressed effectively. The first in a series of events for founders, CEOs, and leaders in healthtech, this morning will bring together some of the brightest minds to discuss how AI might reshape how we discover, test, and personalise the drugs we take. Interoperability, legacy systems, and security implications are still barriers to technology adoption. How do we collaborate to overcome these? And what role does digital have in this future?
Join Draper Esprit to listen to cutting-edge research and lively debate as we look to the future of our health.